Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading ...

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

Baxter International, Inc. BAX recently announced that it has entered into a definitive agreement to divest its Vantive ...

The kidney care business – spanning dialysis machines and related supplies and services – will be renamed Vantive once the sale is concluded, said Baxter in a statement. Carlyle is buying the ...

Baxter stock tumbled Tuesday, undercutting its 50-day line, after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion. Please watch the video at Investors.com - How ...

Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of its acquisition by ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with more flexible, collaborative and accessible care ...

DEERFIELD, Ill., Feb. 3, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the ...